KY216-氨酸复合物捕获VASH2,以抑制NSCLC的转移
Xiao-Yu He1, Cheng-Yan Liu1, Xin-Yu Ding2
1Basic Medical Research Innovation Center for Anti-Cancer Drugs, MOE and State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
一种新型的微管抑制剂,KY216,通过向静脉激素-2 (VASH2) 来抑制非小细胞肺癌 (NSCLC) 转移. 这种机制涉及阻碍表皮-介质细胞过渡 (EMT) 并影响潜在治疗策略的关键分子通路.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 结构生物学 结构生物学
背景情况:
- 非小细胞肺癌 (NSCLC) 的转移是患者死亡的主要原因.
- 微管向剂 (MTA) 显示出抗转移潜力,但其精确的机制尚未完全理解.
研究的目的:
- 阐明NSCLC中MTA KY216的抗转移机制.
- 在NSCLC转移的背景下,研究KY216,αβ-tubulin和静脉激素-2 (VASH2) 之间的相互作用.
主要方法:
- 对KY216与αβ-tubulin.complex中的晶体结构分析.
- 评估KY216对VASH2水平,上皮层-介质细胞过渡 (EMT) 和NSCLC细胞相关分子信号通路的影响.
- 研究miR-429在KY216介导的转移抑制中的作用.
主要成果:
- KY216与曲的αβ-tubulin结合,降低VASH2水平,并抑制NSCLC中的EMT.
- KY216增强了VASH2与α-tubulin的结合,防止了VASH2介导的ZEB1激活,并促进了α-tubulin的异化,抑制了EMT.
- KY216通过miR-429/VASH2/ZEB1轴上调 miR-429,该转录物准VASH2和ZEB1转录物,从而通过miR-429/VASH2/ZEB1轴抑制EMT和NSCLC转移.
结论:
- 通过调节VASH2路径和EMT,KY216有效地抑制NSCLC转移.
- 这项研究揭示了涉及VASH2和miR-429的MTA作用的新机制,为NSCLC提供了潜在的治疗点.
- 了解KY216-图布林相互作用的结构基础,为开发更有效的抗癌剂提供了洞察力.
更多相关视频
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
相关概念视频
Cancer Cell Migration through Invadopodia
Destabilization of Microtubules
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Drugs that Stabilize Microtubules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
